Clinical Trial Update: SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of SP-304 in chronic idiopathic constipation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• SP-304

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Idiopathic Constipation | Phase 2 | Status: COMPLETED | Results posted: 2020-01-02